These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33636206)

  • 1. Integrated clinicopathological and immunohistochemical analysis of gastric adenocarcinoma with hepatoid differentiation: an exploration of histogenesis, molecular characteristics, and prognostic markers.
    He F; Fu Y; Sun Q; Geng P; Zheng Z; Pu X; Shi J; Fan X
    Hum Pathol; 2021 Sep; 115():37-46. PubMed ID: 33636206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic and immunohistochemical characteristics of gastric adenocarcinoma with enteroblastic differentiation: a study of 29 cases.
    Murakami T; Yao T; Mitomi H; Morimoto T; Ueyama H; Matsumoto K; Saito T; Osada T; Nagahara A; Watanabe S
    Gastric Cancer; 2016 Apr; 19(2):498-507. PubMed ID: 25893262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric adenocarcinoma with enteroblastic differentiation should be differentiated from hepatoid adenocarcinoma: A study with emphasis on clear cells and clinicopathologic spectrum.
    Kwon MJ; Byeon S; Kang SY; Kim KM
    Pathol Res Pract; 2019 Sep; 215(9):152525. PubMed ID: 31301878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next-generation sequencing analysis for gastric adenocarcinoma with enteroblastic differentiation: emphasis on the relationship with hepatoid adenocarcinoma.
    Akazawa Y; Saito T; Hayashi T; Yanai Y; Tsuyama S; Akaike K; Suehara Y; Takahashi F; Takamochi K; Ueyama H; Murakami T; Watanabe S; Nagahara A; Yao T
    Hum Pathol; 2018 Aug; 78():79-88. PubMed ID: 29751042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HER2 is frequently overexpressed in hepatoid adenocarcinoma and gastric carcinoma with enteroblastic differentiation: a comparison of 35 cases to 334 gastric carcinomas of other histological types.
    Fujimoto M; Matsuzaki I; Nishino M; Iwahashi Y; Warigaya K; Kojima F; Ono K; Murata SI
    J Clin Pathol; 2018 Jul; 71(7):600-607. PubMed ID: 29305518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gastric adenocarcinoma with enteroblastic differentiation and elevated serum alpha fetoprotein].
    Li QZ; Zhao HB; Ban N; Wang Q; Zhang JJ; Ding SN; Li HH; Zhou ZH
    Zhonghua Bing Li Xue Za Zhi; 2020 Sep; 49(9):886-890. PubMed ID: 32892552
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinicopathological analysis of gastric adenocarcinoma with elevated serum alpha-fetoprotein and enteroblastic differentiation].
    Zan LK; Shen LL; Zhang X; Gao N; Tian BG; Geng XX; Peng X; Li JW; Bu P; Zhao GH
    Zhonghua Zhong Liu Za Zhi; 2024 Jul; 46(7):686-695. PubMed ID: 39034804
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinicopathological characteristics of gastric adenocarcinoma with enteroblastic differentiation and gastric adenocarcinoma with enteroblastic marker expression.
    Abe D; Akazawa Y; Yatagai N; Hayashi T; Ueyama H; Mine S; Fukunaga T; Nagahara A; Yao T; Saito T
    Virchows Arch; 2023 Sep; 483(3):405-414. PubMed ID: 37581693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric hepatoid adenocarcinomas are a genetically heterogenous group; most tumors show chromosomal instability, but MSI tumors do exist.
    Tsuruta S; Ohishi Y; Fujiwara M; Ihara E; Ogawa Y; Oki E; Nakamura M; Oda Y
    Hum Pathol; 2019 Jun; 88():27-38. PubMed ID: 30946937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of hepatocellular markers is useful for prognostication in gastric hepatoid adenocarcinoma.
    Osada M; Aishima S; Hirahashi M; Takizawa N; Takahashi S; Nakamura K; Tanaka M; Maehara Y; Takayanagi R; Oda Y
    Hum Pathol; 2014 Jun; 45(6):1243-50. PubMed ID: 24767858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological study of five cases.
    Murakami T; Yao T; Yatagai N; Yamashiro Y; Saito T; Sakamoto N; Nagahara A
    Histopathology; 2020 Jan; 76(2):325-332. PubMed ID: 31429980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α-Fetoprotein-producing gastric carcinoma and combined hepatocellular and cholangiocarcinoma show similar morphology but different histogenesis with respect to SALL4 expression.
    Ikeda H; Sato Y; Yoneda N; Harada K; Sasaki M; Kitamura S; Sudo Y; Ooi A; Nakanuma Y
    Hum Pathol; 2012 Nov; 43(11):1955-63. PubMed ID: 22516245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the molecular characteristics of the malignant potential of gastric adenocarcinoma with enteroblastic differentiation.
    Wang Y; Wei X; Ke B; Liu J; Guo Y; Liu Y; Chen Y; Ding T; Wang Y; Meng B; Sun B; Zang F
    Histopathology; 2023 Oct; 83(4):631-646. PubMed ID: 37356975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological and molecular characteristics of the alpha-fetoprotein-producing gastric cancer: emphasis on two major subtypes.
    Lu J; Jin M; Zhou X; Chen X; Shao Y; Jiang X
    APMIS; 2022 Mar; 130(3):169-180. PubMed ID: 34862662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinicopathological features of gastric alpha-fetoprotein-producing adenocarcinoma with SWI/SNF complex deletion].
    Yang JZ; Guo XX; Xu C; Hou YY; Yuan W
    Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):52-57. PubMed ID: 38178747
    [No Abstract]   [Full Text] [Related]  

  • 16. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma.
    Ushiku T; Shinozaki A; Shibahara J; Iwasaki Y; Tateishi Y; Funata N; Fukayama M
    Am J Surg Pathol; 2010 Apr; 34(4):533-40. PubMed ID: 20182341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both the serum AFP test and AFP/GPC3/SALL4 immunohistochemistry are beneficial for predicting the prognosis of gastric adenocarcinoma.
    Wang B; Xie Y; Zheng L; Zheng X; Gao J; Liu X; Yuan Y; Li Z; Lu N; Xue L
    BMC Gastroenterol; 2021 Oct; 21(1):408. PubMed ID: 34706681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and clinicopathological features of colorectal adenocarcinoma with enteroblastic differentiation.
    Yamashiro Y; Saito T; Hayashi T; Murakami T; Yanai Y; Tsuyama S; Suehara Y; Takamochi K; Yao T
    Histopathology; 2020 Sep; 77(3):492-502. PubMed ID: 32438490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinicopathological features of gastric adenocarcinoma with enteroblastic differentiation: a report of twelve cases].
    Li JZ; Huang HJ; Chen XY; Chen X
    Zhonghua Bing Li Xue Za Zhi; 2021 Jun; 50(6):626-631. PubMed ID: 34078051
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidence for hepatocellular differentiation in alpha-fetoprotein-negative gastric adenocarcinoma with hepatoid morphology: a study with in situ hybridisation for albumin mRNA.
    Supriatna Y; Kishimoto T; Uno T; Nagai Y; Ishikura H
    Pathology; 2005 Jun; 37(3):211-5. PubMed ID: 16175893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.